Italia markets open in 3 hours 37 minutes

VIR Jan 2025 12.500 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,9500-0,2500 (-20,83%)
In data: 12:55PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente1,2000
Aperto0,9000
Denaro0,7500
Domanda1,0000
Prezzo d'esercizio12,50
Scadenza2025-01-17
Min-Max giorno0,9000 - 0,9500
Contratto - Min-MaxN/D
Volume30
Open Interest493
  • GlobeNewswire

    Vir Biotechnology to Participate in the H.C. Wainwright 4th Annual Hepatitis B Virus (HBV) Conference

    SAN FRANCISCO, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Phil Pang, M.D., Ph.D., Vir’s Executive Vice President, Chief Medical Officer and Interim Head of Research, is participating in a virtual fireside Q&A at the H.C. Wainwright 4th Annual Hepatitis B Virus (HBV) Conference on Wednesday, October 25, at 7:00 a.m. PT / 10:00 a.m. ET. A live webcast of the fireside chat can be accessed under Events & Presentations in the Investors section of the

  • GlobeNewswire

    Vir Biotechnology Announces Multiple Abstracts Highlighting New Chronic Hepatitis B and Hepatitis Delta Data Accepted for Presentation at AASLD’s The Liver Meeting® 2023

    SAN FRANCISCO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that eight abstracts highlighting new data from its chronic hepatitis B (CHB) and chronic hepatitis delta (CHD) clinical programs have been accepted for presentation at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting®, taking place in Boston, MA, from November 10-14, 2023. These include seven poster presentations, one of which is a late-breaking poster, and on

  • GlobeNewswire

    Vir Biotechnology to Provide Business Update and Report Third Quarter 2023 Financial Results on November 2, 2023

    SAN FRANCISCO, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide a corporate update and report financial results for the third quarter ended September 30, 2023, on November 2, 2023. The Company will host a conference call at 4:30 p.m. Eastern Time on November 2, 2023. The corporate update and financial results will be provided via a press release after market close and will be accessible under Press Releases in the Investors section